STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether ProPhase’s board of directors has violated its fiduciary duty by instituting measures that impermissibly interfere with the ability of ProPhase stockholders to elect directors of their choosing.
ProPhase stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or by filling out a contact from on our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
- Kyivstar Group Reaches Nasdaq Listing Milestone with Public Filing of Registration Statement on Form F-4 - June 5, 2025
- Kyivstar Group Reports First Quarter 2025 Financial Results in Conjunction with its Nasdaq Listing Process - June 5, 2025
- Xtract One Announces Third Quarter Fiscal 2025 Results - June 5, 2025
